Euclid Vision Names Dr. Zohra Fadli, as Global Head of R&D and Clinical Affairs
The vision care veteran’s appointment to the top R&D role is a reflection of Euclid’s ongoing commitment to innovation.
Euclid Vision Corp., a global leader in advanced orthokeratology and proactive myopia management initiatives, is pleased to announce the appointment of Zohra Fadli, PhD, to the position of vice president of research and development & clinical affairs. Dr. Fadli brings decades of experience in medical device technology and vision care to her new role at Euclid, including an extensive history in delivering breakthrough ophthalmic contact lenses.
For close to 20 years, Dr. Fadli held global leadership roles in Johnson and Johnson’s (J&J) medical technology divisions. She led the J&J Vision Care Light Management Portfolio, launching a first of its kind light adaptive photochromic contact lens which was named by Time magazine as one of the best inventions in 2018.
Commenting on the appointment, Joseph Boorady, Euclid President and CEO said, “We are excited to bring Dr. Fadli on board at this pivotal time in Euclid’s evolution. Having market leading technologies in two of the fastest growing specialty contact lens markets — Ortho-K and scleral lenses—positions Euclid to best serve our customers today; and having Dr. Fadli heading up R&D, positions us to anticipate and satisfy patient needs tomorrow and in the coming years.”
* Based on internal date